AE-37/GP-2 vaccine

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAE-37/GP-2 vaccine
Drug Alias NameAE37 vaccineCancer vaccine AE37Her-2/neu Breast cancerHer-2/neu Prostate cancerIi-Key/Her-2/neu(776-790) vaccine +[13] 
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 antagonists
TargetsReceptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsTriple Negative Breast NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesGenerex Biotechnology Corp
China Registration ClassN/A

Develop Information

Active CompaniesSan Antonio Military Medical CenterNugenerex Immuno-Oncology Inc
Inactive CompaniesN/A
Active IndicationsTriple Negative Breast NeoplasmsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A